Chang-Jung Chen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chang-Jung Chen has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Hao-Chen Wang
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Republic of China; Center of Comparative Medicine and Research, Innovation Headquarters, National Cheng Kung University, Tainan, Republic of China
42 shared publications - Yan-Shen Shan
Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan
42 shared publications - Ya-Chin Hou
National Cheng Kung University 7 Institute of Clinical Medicine, College of Medicine Tainan, Taiwan
41 shared publications - Chi-Chang Shieh
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan City, Taiwan
40 shared publications - Yi-Ying Wu
Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan. 1
40 shared publications Alarng Chang
Medigen Biotechnology Corporation, Taipei, Republic of China
1 shared publication
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S3 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S3. Expression of MRC1 and ARG1 mRNAs in U937 cells or THP-1 cells cocultured with PANC-1 cells was inhibited by IL-4 neutralization. A, U937, and B, THP-1 cells were cocultured with PANC-1 cells and simultaneously treated with IL-4 neutralizing antibodies. After 72 h of incubation, U937 and THP-1 cells were collected for RT-qPCR to measure MRC1, ARG1, and CYBB gene expression. The bar graphs depict relative protein expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S3 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S3. Expression of MRC1 and ARG1 mRNAs in U937 cells or THP-1 cells cocultured with PANC-1 cells was inhibited by IL-4 neutralization. A, U937, and B, THP-1 cells were cocultured with PANC-1 cells and simultaneously treated with IL-4 neutralizing antibodies. After 72 h of incubation, U937 and THP-1 cells were collected for RT-qPCR to measure MRC1, ARG1, and CYBB gene expression. The bar graphs depict relative protein expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S13 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S13. Treatment with STAT6-CYBB ODNs reduces the proliferation of stromal or epithelial-type tumor cells. A, IF staining for Ki67 and the stromal marker αSMA was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. Each of the images are representative of a field of immuno-stained cells, taken using a ×20 objective with the Olympus BX53 platform. Each composite image includes the nuclear marker DAPI in blue. B, The Bar graph shows the αSMA (left) and Ki67 (right) positive cells relative to the DAPI-stained nuclei in cells in mouse tumor tissue. ***, p < 0.001, compared to mouse tumors treated with the scrambled-ODN. The random of five fields of 3 random sections from each mouse were used to quantify the positive cells. C, IF staining for Ki67 and the epithelial marker CK7 was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. Each of the images are representative of a field of immuno-stained cells, taken using a ×20 objective with the Olympus BX53 platform. Each composite image includes the nuclear marker DAPI in blue. D, The Bar graph shows the CK7 (left) and Ki67 (right) positive cells relative to the DAPI-stained nuclei in cells in mouse tumor tissue. ***, p < 0.001, compared to mouse tumors treated with the scrambled-ODN. The random of five fields of 3 random sections from each mouse were used to quantify the positive cells.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S13 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S13. Treatment with STAT6-CYBB ODNs reduces the proliferation of stromal or epithelial-type tumor cells. A, IF staining for Ki67 and the stromal marker αSMA was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. Each of the images are representative of a field of immuno-stained cells, taken using a ×20 objective with the Olympus BX53 platform. Each composite image includes the nuclear marker DAPI in blue. B, The Bar graph shows the αSMA (left) and Ki67 (right) positive cells relative to the DAPI-stained nuclei in cells in mouse tumor tissue. ***, p < 0.001, compared to mouse tumors treated with the scrambled-ODN. The random of five fields of 3 random sections from each mouse were used to quantify the positive cells. C, IF staining for Ki67 and the epithelial marker CK7 was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. Each of the images are representative of a field of immuno-stained cells, taken using a ×20 objective with the Olympus BX53 platform. Each composite image includes the nuclear marker DAPI in blue. D, The Bar graph shows the CK7 (left) and Ki67 (right) positive cells relative to the DAPI-stained nuclei in cells in mouse tumor tissue. ***, p < 0.001, compared to mouse tumors treated with the scrambled-ODN. The random of five fields of 3 random sections from each mouse were used to quantify the positive cells.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S10 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S10. JAK/STAT6/HDAC2 is the downstream signaling in regulating CYBB expression in THP-1 cells. A, RT-qPCR analysis for IL-4 expression was performed in THP-1 cells co-cultured with different pancreatic cell lines. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. B, RT-qPCR analysis for CD86 and MSR1(CD204) expression was performed in THP-1 cells co-cultured with different pancreatic cell lines. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. C, THP-1 cells were cocultured with PANC-1 cells and simultaneously treated with IL-4 neutralizing antibodies. After 72 h of incubation, THP-1 cells were collected for Western blotting to measure M1/M2 markers, CYBB, and GAPDH protein expression. D, Time-dependent effect of IL-4 (20 ng/mL) on CD86, CD204, CD206 (MRC1), STAT6, HDAC2, and CYBB protein expression was determined by Western blotting. E, THP-1 cells were pre-treated with the JAK1 inhibitor (Ruxolitinib, 10 μM), the JAK3 inhibitor (Tofacitinib, 50 μM), the STAT6 inhibitor (AS1517499, 250 nM), and the HDAC inhibitor (TSA, 10 uM) for 24h and then were treated with IL-4 (20 ng/mL) for 1h. Cell lysates were collected for Western blot analysis to measure indicated protein expression.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S10 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S10. JAK/STAT6/HDAC2 is the downstream signaling in regulating CYBB expression in THP-1 cells. A, RT-qPCR analysis for IL-4 expression was performed in THP-1 cells co-cultured with different pancreatic cell lines. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. B, RT-qPCR analysis for CD86 and MSR1(CD204) expression was performed in THP-1 cells co-cultured with different pancreatic cell lines. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. C, THP-1 cells were cocultured with PANC-1 cells and simultaneously treated with IL-4 neutralizing antibodies. After 72 h of incubation, THP-1 cells were collected for Western blotting to measure M1/M2 markers, CYBB, and GAPDH protein expression. D, Time-dependent effect of IL-4 (20 ng/mL) on CD86, CD204, CD206 (MRC1), STAT6, HDAC2, and CYBB protein expression was determined by Western blotting. E, THP-1 cells were pre-treated with the JAK1 inhibitor (Ruxolitinib, 10 μM), the JAK3 inhibitor (Tofacitinib, 50 μM), the STAT6 inhibitor (AS1517499, 250 nM), and the HDAC inhibitor (TSA, 10 uM) for 24h and then were treated with IL-4 (20 ng/mL) for 1h. Cell lysates were collected for Western blot analysis to measure indicated protein expression.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S14 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S14. The expression of Granzyme B is significantly increased in mouse pancreatic tumors treated with STAT6-CYBB ODN. A, IHC staining for the cytotoxic marker Granzyme B was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. B, The bar graph depicts the average numbers of granzyme B positive cells per field. ***, p < 0.001, compared to the scrambled ODN treatment group. Five random fields of 3 random sections from each mouse were used to quantify the positive cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S14 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S14. The expression of Granzyme B is significantly increased in mouse pancreatic tumors treated with STAT6-CYBB ODN. A, IHC staining for the cytotoxic marker Granzyme B was performed in KPC tumors from the scrambled ODN, mutated ODN, and STAT6-CYBB ODN-treated mice. B, The bar graph depicts the average numbers of granzyme B positive cells per field. ***, p < 0.001, compared to the scrambled ODN treatment group. Five random fields of 3 random sections from each mouse were used to quantify the positive cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S4 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S4. H2O2 cannot independently activate JAK/STAT6 phosphorylation. The effect of H2O2 (100 nM) on JAK1, JAK3, STAT6, and CYBB total protein and phosphorylated protein expression was analyzed with Western blotting at indicated time points. GAPDH was used as a loading control. The bar graph depicts the ratio of CYBB/GAPDH. ns, not significant, compared to 0 h. Data represent the mean of 3 independent experiments.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S4 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S4. H2O2 cannot independently activate JAK/STAT6 phosphorylation. The effect of H2O2 (100 nM) on JAK1, JAK3, STAT6, and CYBB total protein and phosphorylated protein expression was analyzed with Western blotting at indicated time points. GAPDH was used as a loading control. The bar graph depicts the ratio of CYBB/GAPDH. ns, not significant, compared to 0 h. Data represent the mean of 3 independent experiments.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S1 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S1. High CD204 and low CYBB expression are associated with poor survival in pancreatic cancer patients. A, Immunofluorescence (IF) staining for CYBB expression was performed on tissue microarrays of pancreatic cancer. White arrows indicate CYBB-positive cells. DAPI was used for staining cell nuclei (blue). B and C, Kaplan-Meier survival analysis was performed to evaluate the association of CD204 expression with OS and DFS in pancreatic cancer patients. D and E, Kaplan-Meier survival analysis was performed to evaluate the association of CYBB expression with OS and DFS in pancreatic cancer patients.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S1 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S1. High CD204 and low CYBB expression are associated with poor survival in pancreatic cancer patients. A, Immunofluorescence (IF) staining for CYBB expression was performed on tissue microarrays of pancreatic cancer. White arrows indicate CYBB-positive cells. DAPI was used for staining cell nuclei (blue). B and C, Kaplan-Meier survival analysis was performed to evaluate the association of CD204 expression with OS and DFS in pancreatic cancer patients. D and E, Kaplan-Meier survival analysis was performed to evaluate the association of CYBB expression with OS and DFS in pancreatic cancer patients.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S9 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S9. Knocking down STAT6 or HDAC2 in U937 cells prevents pancreatic cancer cells co-culture-induced CYBB downregulation. A, B, and C, RT-qPCR analysis for M1/M2 markers and CYBB in shSTAT6 or shHDAC2 U937 cells co-cultured with PANC-1 cells for 72h. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. D, shSTAT6 or shHDAC2 U937 cells were co-cultured with PANC-1 cells for 72h. Cell lysates were subjected to Western blotting for indicated proteins. GAPDH was used as a loading control. The bar graph depicts the ratio of CYBB/GAPDH. **, p < 0.01; ***, p < 0.001, compared with the group without co-culture. Data represent the mean of 3 independent experiments.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S9 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S9. Knocking down STAT6 or HDAC2 in U937 cells prevents pancreatic cancer cells co-culture-induced CYBB downregulation. A, B, and C, RT-qPCR analysis for M1/M2 markers and CYBB in shSTAT6 or shHDAC2 U937 cells co-cultured with PANC-1 cells for 72h. The bar graphs depict relative mRNA expression. ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments. D, shSTAT6 or shHDAC2 U937 cells were co-cultured with PANC-1 cells for 72h. Cell lysates were subjected to Western blotting for indicated proteins. GAPDH was used as a loading control. The bar graph depicts the ratio of CYBB/GAPDH. **, p < 0.01; ***, p < 0.001, compared with the group without co-culture. Data represent the mean of 3 independent experiments.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S11 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S11. STAT6-CYBB ODN-treated macrophages can activate the proliferation of Jurkat cells and αCD3-PBMC cells. A, and B, After scrambled ODN (SC-ODN) and STAT6-CYBB ODN treatment, U937 cells were cocultured with PANC-1 cells for 72h. After coculture with PANC-1 cells, SC-ODN treated macrophages or STAT6-CYBB ODN treated macrophages were cocultured with CFSE-staining Jurkat cells or CFSE-staining αCD3-PBMC cells for 72h. Flow cytometry analysis of cell proliferation in Jurkat cells and αCD3-PBMC was performed. C, and D, The bar graphs indicate the relative percentages of CFSE-labeled Jurkat cells or αCD3-PBMC cells as proliferative index. *, p < 0.05; ***, p < 0.001, compared to the Jurkat cell or αCD3-PBMC cell only group. Data represent the mean of 3 independent experiments.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S11 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S11. STAT6-CYBB ODN-treated macrophages can activate the proliferation of Jurkat cells and αCD3-PBMC cells. A, and B, After scrambled ODN (SC-ODN) and STAT6-CYBB ODN treatment, U937 cells were cocultured with PANC-1 cells for 72h. After coculture with PANC-1 cells, SC-ODN treated macrophages or STAT6-CYBB ODN treated macrophages were cocultured with CFSE-staining Jurkat cells or CFSE-staining αCD3-PBMC cells for 72h. Flow cytometry analysis of cell proliferation in Jurkat cells and αCD3-PBMC was performed. C, and D, The bar graphs indicate the relative percentages of CFSE-labeled Jurkat cells or αCD3-PBMC cells as proliferative index. *, p < 0.05; ***, p < 0.001, compared to the Jurkat cell or αCD3-PBMC cell only group. Data represent the mean of 3 independent experiments.
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table S3 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Table S3. Clinical parameters of the 100 pancreatic cancer patients for RNA sequencing
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S3 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Table S3. Clinical parameters of the 100 pancreatic cancer patients for RNA sequencing
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure S2 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S2. IL-4 levels were increased in the co-culture condition medium of U937 cells and PANC-1 cells. The co-culture condition medium of U937 cells and PANC-1 cells were collected at 0, 12, and 72 hours. ELISA was performed to detect the concentrations of IL-4. The bar graphs depict relative protein expression. *, p < 0.05; ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments.
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure S2 from Blocking M2-Like Macrophage Polarization Using Decoy Oligodeoxynucleotide-Based Gene Therapy Prevents Immune Evasion for Pancreatic Cancer Treatment
Supplementary Figure S2. IL-4 levels were increased in the co-culture condition medium of U937 cells and PANC-1 cells. The co-culture condition medium of U937 cells and PANC-1 cells were collected at 0, 12, and 72 hours. ELISA was performed to detect the concentrations of IL-4. The bar graphs depict relative protein expression. *, p < 0.05; ***, p < 0.001, significant differences between groups. Data represent the mean of 3 independent experiments.